|
|
||||||||
1 Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK
2 Oxford Centre for Molecular Sciences, Department of Chemistry, University of Oxford, Oxford OX1 3QH, UK
3 Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK
Reprint requests to: William James, Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK; e-mail: william.james{at}path.ox.ac.uk; fax: 44 (1865) 275501.
At the heart of the pathogenesis of transmissible spongiform encephalopathies (TSEs), such as BSE, scrapie, and CreutzfeldtJakob disease, lies a poorly understood structural rearrangement of PrP, an abundant glycoprotein of the nervous and lymphoid systems. The normal form (PrPC), rich in
-helix, converts into an aberrant ß-sheet-dominated form (PrPSc), which seems to be at the center of the pathotoxic symptoms observed in TSEs. To understand this process better at a molecular level, we have studied the interactions between different peptides derived from bovine PrP and their structural significance. We show that two unstructured peptides derived from the central region of bovine PrP, residues 115133 and 140152, respectively, interact stoichiometrically under physiological conditions to generate ß-sheet-dominated fibrils. However, when both peptides are incubated in the presence of a third peptide derived from an adjoining
-helical region (residues 153169), the formation of ß-sheet-rich fibrils is abolished. These data indicate that native PrPC helix 1 might inhibit the strong intrinsic ß-sheet-forming propensity of sequences immediately N-terminal to the globular core of PrPC, by keeping in place intrachain interactions that would prevent these amyloidogenic regions from triggering aggregation. Moreover, these results indicate new ways in which PrPSc formation could be prevented.
Keywords: Prions; ß-amyloid; BSE; peptide; fibrillogenesis
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Tahiri-Alaoui and W. James Rapid formation of amyloid from {alpha}-monomeric recombinant human PrP in vitro Protein Sci., April 1, 2005; 14(4): 942 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tahiri-Alaoui, A. C. Gill, P. Disterer, and W. James Methionine 129 Variant of Human Prion Protein Oligomerizes More Rapidly than the Valine 129 Variant: IMPLICATIONS FOR DISEASE SUSCEPTIBILITY TO CREUTZFELDT-JAKOB DISEASE J. Biol. Chem., July 23, 2004; 279(30): 31390 - 31397. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ventura, J. Zurdo, S. Narayanan, M. Parreno, R. Mangues, B. Reif, F. Chiti, E. Giannoni, C. M. Dobson, F. X. Aviles, et al. Short amino acid stretches can mediate amyloid formation in globular proteins: The Src homology 3 (SH3) case PNAS, May 11, 2004; 101(19): 7258 - 7263. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rhie, L. Kirby, N. Sayer, R. Wellesley, P. Disterer, I. Sylvester, A. Gill, J. Hope, W. James, and A. Tahiri-Alaoui Characterization of 2'-Fluoro-RNA Aptamers That Bind Preferentially to Disease-associated Conformations of Prion Protein and Inhibit Conversion J. Biol. Chem., October 10, 2003; 278(41): 39697 - 39705. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |